1083 related articles for article (PubMed ID: 19098844)
21. [Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study].
Cheng H; Hu FL; Zhang GX; Shi RH; Du YQ; Li ZS; Han W; Li YQ; Wu QD; Qian KD
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):79-82. PubMed ID: 20356486
[TBL] [Abstract][Full Text] [Related]
22. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
23. [Methods to optimize the management of Helicobacter pylori infection. The comparative efficacy of the triple and quadruple therapy used as a first line therapy].
Grigor'ev PIa; Iakovenko AV; Iakovenko EP; Vasil'ev IV; Komleva IuV; Oprishchenko IV; Aldiiarova MA
Eksp Klin Gastroenterol; 2004; (5):31-8, 148. PubMed ID: 15770858
[TBL] [Abstract][Full Text] [Related]
24. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
[TBL] [Abstract][Full Text] [Related]
25. 'Rescue' therapies for the management of Helicobacter pylori infection.
Di Mario F; Cavallaro LG; Scarpignato C
Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
[TBL] [Abstract][Full Text] [Related]
26. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Pontone S; Standoli M; Angelini R; Pontone P
Dig Liver Dis; 2010 Aug; 42(8):541-3. PubMed ID: 20061196
[TBL] [Abstract][Full Text] [Related]
28. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
29. High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
Severi C; Abdullahi M; Tari R; Vannella L; Marcheggiano A; Capoccia D; Leonetti F; Osborn J; Annibale B
Dig Liver Dis; 2009 Aug; 41(8):555-8. PubMed ID: 19179127
[TBL] [Abstract][Full Text] [Related]
30. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
31. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
[TBL] [Abstract][Full Text] [Related]
32. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
33. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
[TBL] [Abstract][Full Text] [Related]
34. Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
Cerqueira RM; Correia MR; Fernandes CD; Vilar H; Manso MC
Obes Surg; 2013 Feb; 23(2):145-9. PubMed ID: 23054570
[TBL] [Abstract][Full Text] [Related]
35. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
[TBL] [Abstract][Full Text] [Related]
36. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
Sullivan B; Coyle W; Nemec R; Dunteman T
Am J Gastroenterol; 2002 Oct; 97(10):2536-9. PubMed ID: 12385435
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
Cetinkaya ZA; Sezikli M; Güzelbulut F; Coşgun S; Düzgün S; Kurdaş OO
Helicobacter; 2010 Apr; 15(2):143-7. PubMed ID: 20402816
[TBL] [Abstract][Full Text] [Related]
39. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
40. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
